Companies › BMEA
BIOMEA FUSION INC (BMEA)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001840439 · EDGAR filings · Updated 2026-06-12
BIOMEA FUSION INC (BMEA) has reported institutional ownership of 33.7%, with 64 institutional managers holding positions valued at $37.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-11 — Current report (8-K) filed
- 2026-05-11 — Quarterly report (10-Q) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BIOMEA FUSION INC has 64 institutional holders and institutional ownership of 33.7%.
Insider activity
Insiders reported 17 transactions (4 buys, 0 sells) across 3 reporting insiders, with a net reported value of $196.4K.
Data flags from SEC filings
Related companies
ACTUATE THERAPEUTICS INC (ACTU) · TENAYA THERAPEUTICS INC (TNYA) · Cardiol Therapeutics Inc (CRDL) · INSPIREMD INC (NSPR) · iBio Inc (IBIO) · PROTALIX BIOTHERAPEUTICS INC (PLX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-12.